San Francisco, December 6, 2021/PRNewswire/-According to a new report from Grand View Research, Inc, the global hospital consumables market is expected to reach USD 713.1 billion by 2028, a compound annual growth rate during the forecast period The rate is 10.89%. Hospitals, private medical institutions and patients, especially in developed countries, are gradually turning to disposable hospital consumables due to the convenience and safety provided by these products. Therefore, the demand for products is growing rapidly on a global scale, thereby driving market growth. In addition, the increasing prevalence of hospital-acquired infections (HAI) is creating high product demand in hospitals and other healthcare environments.

The main insights and findings of the report:

The non-woven disposable products segment has the largest revenue share in 2020 and will grow at a stable compound annual growth rate in the forecast year, maintaining a leading market position

This increase is attributable to the high prevalence of HAI and the subsequent increase in the number of hospitalizations for surgery

The Asia-Pacific market is expected to achieve the fastest compound annual growth rate from 2021 to 2028

This increase is due to population growth and the rapid expansion of the medical tourism sector in the region

Major players are more focused on business strategies such as mergers and acquisitions, partnerships and new product launches to strengthen their foothold in the global market

Read the 90-page market research report, "By product (non-woven disposable products, disposable medical gloves), by region (North America, Asia Pacific) and market segment forecasts, the size of the hospital consumables market by product from 2021 to 2028, Sharing and trend analysis reports", via Grand View Research

For example, out of every 100 hospitalized patients, 7 are in developed countries and 10 are affected by at least one health care-associated infection (HCAI) in developing countries. A number of measures including the use of disposable and sterile products, disposable gloves, medical gauze, tape, surgical kits and trays, and other disposable hospital consumables are being used to prevent and reduce the prevalence of HAI. In addition, the ever-expanding infrastructure of medical institutions and the ever-increasing maintenance and sanitation needs are further driving market growth.

Many hospitals and healthcare centers are paying great attention to improving the quality of infrastructure and maintaining the efficiency of health and operating systems, which will have a positive impact on market growth. In addition, the large population base of developed countries such as the United States can afford and afford better quality medical care. According to data from CMS.gov, U.S. healthcare expenditures increased by 4.6% in 2019, reaching 3.8 trillion U.S. dollars or $11,582 per capita, accounting for 17.7% of U.S. GDP. Therefore, increasing healthcare expenditure is also one of the key factors that stimulate market growth.

Grand View Research has segmented the global hospital consumables market based on products and regions:

Hospital consumables product outlook (revenue, million dollars, 2016-2028)

Regional outlook for hospital consumables (revenue, million dollars, 2016-2028)

List of major players in the hospital consumables market

B. Braun Melsungen AG

Fresenius Medical Care AG & Co. KGaA

View more research related to hospital consumables conducted by Grand View Research:

Hospital supplies market-The global hospital supplies market is entitled to witness significant growth during the forecast period due to the increasing awareness of the control of hospital-acquired infections (HAI). The decline of private medical insurance, the increasing popularity of home care services, and strict government-led supervision are the main limiting factors hindering the growth of the hospital equipment and supplies market.

Medical disposable products market-The global medical disposable products market is worth 318.3 billion U.S. dollars in 2020, and it is expected to expand at a compound annual growth rate (CAGR) of 16.7% from 2021 to 2028. The growth of the market is attributed to the number of surgical procedures, the increasing incidence of hospital-acquired infections (HAI), the increasing prevalence of chronic diseases leading to longer hospital stays, and the global impact of the COVID-19 epidemic.

U.S. hospital consumables market-The size of the U.S. hospital consumables market in 2017 was 34.54 billion U.S. dollars. It is expected to grow at a compound annual growth rate of 5.6% during the forecast period. In the United States, more and more surgeries mean an increase in the use of hospital consumables.

View Grand View Research's coverage of the global medical device industry

Visit Grand View Compass, our BI enables an intuitive market research database of more than 10,000 reports

Grand View Research is a US-based market research and consulting company that provides joint and customized research reports and consulting services. The company is registered in California, is headquartered in San Francisco, has more than 425 analysts and consultants, and adds more than 1,200 market research reports to its huge database every year. These reports provide in-depth analysis of 46 industries in 25 major countries around the world. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and well-known academic institutions understand the global and regional business environment and seize future opportunities.

Sherry James Enterprise Sales Specialist, Grand View Research, Inc., USA Tel: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com Website: https://www.grandviewresearch. Follow us on com: LinkedIn | Twitter

View the original text: https://www.prnewswire.com/news-releases/hospital-consumables-market-size-worth-713-1-billion-by-2028-grand-view-research-inc-301437685.html

SOURCE Grand View Research, Inc.

Stock selector and hedge manager Cathy Wood caused some sensation last year when her ARK Innovation ETF outperformed the S&P 500 by an order of magnitude. From the trough of the pandemic in March to the end of 2020, the S&P index has risen by 68%, while Wood's flagship fund has soared by 153%. This is an amazing performance. Wood made a wise choice last year, targeting investment in technology companies, remote connectivity and telemedicine. During the lock-in phase, businesses in all these market segments have achieved tremendous growth

(Bloomberg)-Due to the rising global low-light infection rate and the turbulence in President Joe Biden's economic agenda, investor sentiment is sluggish, stimulating the selling of stocks, stock futures and oil, while boosting sovereign bonds. "Stern warning" for vaccination in the face of Covid surge

Buffett turned millions into billions without the darling of electric cars in the U.S.

(Bloomberg)-Monday's Asian trading hours showed a decisive hedging tone: US stock index futures fell, US Treasury bonds rose, and risk-sensitive currencies fell, as investors worried that the new lockdown would slow the speed of new variants. Most from Bloomberg read that South Africa’s hospitalization rate plummeted Omicron Wave Biden issued a “stern warning” about vaccination during the Covid surge

Due to concerns about Fed policy and the rapidly spreading omicron variant of COVID-19, US stock index futures fell on Sunday night after a week of declines on Wall Street.

The market rebound has hit investors financially and spiritually, Omicron’s concerns are intensifying, and the blockade is coming back

Features-Major US stock markets did not follow the script in 2021. As of December 16, the index's return rate was 26%, which is much higher than the average increase of approximately 10% predicted by strategists at the beginning of the year.

In this article, we discussed 10 electric vehicle stocks worth buying in 2022. If you want to skip our detailed analysis of these stocks, please go directly to 5 electric car stocks worth buying in 2022. In 2021, the sales of electric vehicles in China and Europe have surged, and these countries reported 1.2 million and 1.4 […]

At first glance, Alibaba Group Holdings seems to be an attractive deal. Alibaba and other Chinese companies continue to face the uncertainty of stock delisting, geopolitical tensions and Chinese regulatory crackdowns. As previously reported by Barron’s, some fund managers have recently started buying Alibaba stock.

Many names across the Nasdaq have fallen by 30%, 50%, and 75% from their highs. At the same time, the consumer electronics giant Apple (NASDAQ: AAPL) is close to a 52-week high and has risen by 40% in the past 12 months, indicating that investors are selling smaller, riskier stocks and Buy large mature stocks such as Apple. This is why Apple may be the biggest disappointment in 2022.

The economist and consultant of Allianz SE said that high inflation will continue.

REITs are paying huge dividends from various commercial real estate holdings.

This is why they chose BioNTech (NASDAQ: BNTX), Eli Lilly (NYSE: LLY) and Novavax (NASDAQ: NVAX). Prosper Junior Bakiny (BioNTech): BioNTech and Pfizer (NYSE: PFE) have collaborated to develop the market-leading coronavirus vaccine Comirnaty.

Nvidia GPU powers self-driving cars and cloud games, and the chip giant is also rapidly expanding into the meta universe. Is NVIDIA stock worth buying?

(Bloomberg)-Cruise LLC CEO Dan Ammann received a call from General Motors CEO Mary Barra on the afternoon of December 16. She told Amman that he was fired from a robotic taxi startup controlled by General Motors through a majority stake, according to people familiar with the matter. Thousands of new

Today, there are many options for investing in vaccine stocks. Adria Cimino (Ocugen): Due to optimism about potential coronavirus vaccine sales, Ocugen surged by more than 700% in the weeks earlier this year. The biotech company cooperated with Bharat Biotech to jointly commercialize the company's vaccine Covaxin in the United States. The transaction was later expanded to include Canada.

In this article, we discussed the 10 dividend stocks that Joel Greenblatt's Gotham Asset Management considers the most worth buying. You can skip our detailed analysis of Greenblatt hedge funds and their returns over the years and go straight to the 5 dividend stocks to buy from Joel Greenblatt’s Gotham Asset Management. Joel Greenblatt […]

The breadth of the market showed a crash before the stock market crashes in 2018 and 2020, triggering red flags that led to a drop of 20-35% from the peak, as shown in the comparison chart between the S&P 500 Index (SPX) and the breadth of the market below.

(Bloomberg) - China's real estate stocks plummeted to near a five-year low after a series of asset sales intensified concerns that stock investors will bear the brunt as developers unload projects to repay debt. Most of the reading comes from Bloomberg. South Africa’s hospitalization rate plummeted in Omicron WaveBiden, which issued a “severe warning” on vaccination during the Covid surge.

For some companies that build charging networks for electric vehicles, this is a rough road, but one company has gained the trust of its new directors. ChargePoint Holdings (stock code: CHPT) stock halved in 2021, and this year was a year of surge in the broader market. ChargePoint director Susan Heystee purchased 12,500 shares at a price of US$250,000 on December 10, at an average price of US$19.95 per share.